Radio Advisory's Rachel Woods sat down with health plan, workforce and value-based care experts Mallory Kirby, Eliza Dailey, and Katie Everts to explain payvider relationships, why they're becoming more common, and how to determine if becoming a payvider partnership is feasible for your organization.
Mark Cuban's Cost Plus Drug Company has partnered with the Purchaser Business Group on Health on a new venture that aims to lower drug costs for self-insured employers—a move that some experts say may be "pulling the rug out from under" legacy pharmacy benefit managers.
Earlier this year, FDA issued draft guidance warning patients of potential risks associated with Lasik surgery, prompting praise from some, but backlash from surgeons who say the agency's "information is one-sided and will needlessly frighten patients," Roni Caryn Rabin writes for the New York Times.
One of executives' primary concerns about remote work is decreased employee engagement—but data suggest that remote and hybrid employees are increasingly collaborating through impromptu meetings. Writing for the Harvard Business Review, Andrew Brodsky and Mike Tolliver explain five "major ways" remote meetings have changed over time, and provide three "actionable insights" from their data.
Pfizer and Clear Creek Bio are partnering to develop a new Covid-19 treatment, long Covid may cost the U.S. economy almost $4 trillion, and more in this week's roundup of Covid-19 news.
Pfizer on Wednesday announced that FDA will fast-track its respiratory syncytial virus vaccine candidate under the agency's priority review program, in today's bite-sized hospital and health industry news from California, Hawaii, and New York.
